<DOC>
	<DOC>NCT03100474</DOC>
	<brief_summary>A global post approval study to collect safety and effectiveness data related to ExAblate Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson's Movement Disorders, or Neuropathic Pain within the thalamus and/or pallidum.</brief_summary>
	<brief_title>Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:</brief_title>
	<detailed_description>A global, multi-center, open-label, observational registry to capture safety and effectiveness data related to ExAblate Neuro, an MRI guided focused ultrasound device designed to lesion tissue deep within the brain using sound waves without the need for craniotomy. This registry includes certain regional and country specific approved thalamotomy and pallidotomy procedures using ExAblate Neuro for the treatment of various neurologic disorders such as essential tremor, Parkinson's movement disorders, and neuropathic pain. Treatment targets/indications are country/region dependent based on approved labeling within that region.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Tremor</mesh_term>
	<mesh_term>Essential Tremor</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<criteria>Meets labeling indication for use per information for prescribers Target is accessible by Focused Ultrasound per treatment planning parameters Do not agree to participate or who are unlikely to participate over an extended period of time</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>tremor</keyword>
	<keyword>Parkinson's</keyword>
	<keyword>movement</keyword>
	<keyword>neuropathic</keyword>
	<keyword>pain</keyword>
</DOC>